Leading Cardiovascular Physicians and Researchers Present New Science in Heart Failure Prevention
The Academy's Biochemical Pharmacology Discussion Group and the New York Chapter of the American Chemical Society host a Translational Medicine symposium.
Published September 15, 2010
Heart failure, along with sudden cardiac death, is a leading cause of mortality in the U.S. Development of effective therapies has been hampered by a lack of understanding of the mechanisms that cause these disorders. A September 28 symposium at the New York Academy of Sciences, “Targeted Molecular Therapy for Preventing Heart Failure and Sudden Cardiac Death,” will review the biology and current therapeutic approaches for treating sudden cardiac death, and discuss current research efforts to identify useful molecular targets and practical therapeutic approaches to combat this disease. Speakers will also review current clinical treatments, and discuss new approaches to address this unmet medical need.
WHAT: A Scientific Symposium: Targeted Molecular Therapy for Preventing Heart Failure and Sudden Cardiac Death
Fadi G. Akar, PhD, Assistant Professor of Medicine, Mt. Sinai School of Medicine, and adjunct Assistant Professor, Division of Cardiology and Computational Medicine, Johns Hopkins University
Roger J. Hajjar, MD, Director of the Cardiovascular Research Institute, and Arthur & Janet C. Ross Professor of Medicine at Mount Sinai School of Medicine
Mariell Jessup, MD, Professor of Medicine, University of Pennsylvania School of Medicine, Associate Chief - Clinical Affairs, Cardiovascular Division of Medicine and Medical Director, Heart and Vascular Center at Penn Medicine
Walter J. Koch, PhD, W. W. Smith Professor of Medicine, Director, Center for Translational Medicine, and Vice Chair for Research, Department of Medicine, Thomas Jefferson University
Evangelia (Litsa) Kranias, PhD, Distinguished University Research Professor, Hanna Professor of Cardiology, Chair, Department of Pharmacology and Cell Biophysics, and co-Director of the Cardiovascular Center of Excellence, University of Cincinnati College of Medicine
WHEN: Tuesday, September 28, 2010 | 1:00 pm – 5:00 pm
WHERE: The New York Academy of Sciences
7 World Trade Center, 250 Greenwich St., 40th floor, New York, NY
This symposium is presented by the New York Academy of Sciences' Biochemical Pharmacology Discussion Group and the New York Chapter of the American Chemical Society, and is part of the Academy’s Translational Medicine Initiative, sponsored by the Josiah Macy Jr. Foundation. For more information see www.nyas.org/heartfailure. Media must register in advance by contacting Adrienne Burke, Director, Public Outreach, the New York Academy of Sciences, at email@example.com, 212.298.8655.